Ulrika Broberg

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies

Hanjing Xie, Laimonas Griškevičius, Lars Ståhle et al. · European Journal of Pharmaceutical Sciences · 2005 · 101 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +6

Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.

Amy S. Morgan, Polly E. Sanderson, Richard F. Borch et al. · PubMed · 1998 · 78 citations

Tumor Efficacy, Cancer Immunosurveillance, Oncogenic Agent +15

Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome P450 genes by ciprofloxacin

H-J Xie, Laimonas Griškevičius, Ulrika Broberg et al. · Bone Marrow Transplantation · 2003 · 42 citations

Biochemistry, Medicine, Cytochrome P450 Genes +6

Effect of cyclophosphamide on gene expression of cytochromes P450 and β-actin in the HL-60 cell line

Hanjing Xie, Stefan Lundgren, Ulrika Broberg et al. · European Journal of Pharmacology · 2002 · 21 citations

Molecular Pharmacology, Biochemistry, Medicine +13

Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML

Sylvain Lehmann, Sofia Bengtzén, Ulrika Broberg et al. · Leukemia Research · 2000 · 20 citations

Hematological Malignancy, Leukemic Blast Cells, Medicine +11